Superworth

TriSalus Life Sciences PE ratio TLSI

Share price divided by earnings per share over the last twelve months, since 2022.

Today, Oct 23, 2026
n/m
losses over the last year
Last meaningful
344×
Jul 2023
Peer median
19.7×

TriSalus Life Sciences has no meaningful PE ratio today: it lost $1.30 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Jul 2023, at 344×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2023344×32.5×353×
202232.4×28.3×82.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest TriSalus Life Sciences' size, closest first, today.

CompanyPE ratio
TLSITriSalus Life Sciencesn/m
UTMDUtah Medical Products22.6×
PDEXPro DEX15.1×
INFUInfuSystem34.0×
EMBCEmbecta4.6×
KEQUKewaunee Scientific11.9×
TCMDTactile Systems Technology21.9×
MDXGMimedx97.8×
MOVMovado17.5×
APTAlpha Pro Tech13.6×
IRMDIradimed47.9×
Peer median19.7×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on TriSalus Life Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.